DNA damage and repair in lymphoblastoid cell lines from normal donors and fragile X syndrome patients

Arch Med Res. 2002 Mar-Apr;33(2):128-35. doi: 10.1016/s0188-4409(01)00376-9.

Abstract

Background: Because lymphocytes from fragile X patients have been reported as hypersensitive to bleomycin-induced chromatid breaks and because the number of trinucleotide repeats in families with fragile X syndrome has a propensity to expand, we have investigated the possibility that fragile X cells may be hypersensitive to DNA damage and have a lower capacity for DNA repair.

Methods: Lymphocytes from normal and fragile X syndrome donors were immortalized by Epstein-Barr virus transformation. Characteristics of fragile X syndrome including the folate-sensitive fragile site on chromosome Xq27.3, length of CGG repeat expansion, and FMRP expression in Epstein-Barr virus-transformed lymphoblastoid cell lines were analyzed by standard cytogenetic methods, Southern blot, and Western blot, respectively. Analysis of DNA damage and repair induced by hydrogen peroxide, bleomycin, ethyl methanesulfonate, 4-nitroquinoline-N-oxide, etoposide, and mitomycin C was carried out by single-cell gel electrophoresis assay (known as comet assay).

Results: Lymphoblastoid cell lines from fragile X donors had a folate-sensitive fragile site on chromosome Xq27.3, no or low FMRP expression, and expansion of the CGG repeat. Results of comet assay showed that fragile X cells were not more sensitive to mutagen-induced DNA strand breaks and did not have lower DNA repair capacity in comparison with normal cells. Furthermore, one fragile X cell line showed hyposensitivity to DNA strand breaks induced by hydrogen peroxide, bleomycin, and ethyl methansulfonate.

Conclusions: The results of this study do not support the notion that CGG trinucleotide expansion in fragile X syndrome is caused by permanent deficiency in DNA repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Nitroquinoline-1-oxide / pharmacology
  • Antibiotics, Antineoplastic / pharmacology
  • Antineoplastic Agents, Alkylating / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Bleomycin / pharmacology
  • Carcinogens / pharmacology
  • Cell Line
  • Cell Transformation, Viral
  • Comet Assay
  • DNA Damage*
  • DNA Repair*
  • Ethyl Methanesulfonate / pharmacology
  • Etoposide / pharmacology
  • Female
  • Fragile X Mental Retardation Protein
  • Fragile X Syndrome / genetics*
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Lymphocytes / drug effects
  • Lymphocytes / physiology*
  • Male
  • Mitomycin / pharmacology
  • Nerve Tissue Proteins / genetics
  • Oxidants / pharmacology
  • RNA-Binding Proteins*
  • Trinucleotide Repeat Expansion / genetics

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Phytogenic
  • Carcinogens
  • FMR1 protein, human
  • Nerve Tissue Proteins
  • Oxidants
  • RNA-Binding Proteins
  • Bleomycin
  • Fragile X Mental Retardation Protein
  • Mitomycin
  • 4-Nitroquinoline-1-oxide
  • Etoposide
  • Ethyl Methanesulfonate
  • Hydrogen Peroxide